The data suggested that PLOD2 was associated with poor prognosis of lung cancer patients (Figure 1a), especially in lung adenocarcinoma patients (Figure 1b) but not in lung squamous cell carcinoma patients (Figure 1c). Here, PLOD2 is linked to lung carcinoma.